Michael Alpert Email

Founder . Emmune

Current Roles

Employees:
5
Revenue:
$775k
About
Emmune, Inc. is a start-up biotechnology company that has a novel approach for treating and preventing HIV infection. We engineered a synthetic antibody from the receptors that HIV uses to infect T cells, CD4 and CCR5. Because this synthetic antibody, known as “eCD4-Ig,” is built from the viral receptor and co-receptor, it recognizes 100% of HIV-1 isolates. A single intramuscular inoculation with an AAV vector expressing eCD4-Ig protected monkeys from multiple intravenous challenges with live virus.
Emmune Address
130 Scripps Way
Jupiter, FL
Emmune Email

#1 Startup Dataset

Growth rates, revenue data, direct competitors and contact details.